Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Hypertension. 2019 Dec 2;75(1):183–192. doi: 10.1161/HYPERTENSIONAHA.119.13866

Table 1.

Characteristics of study participants

PATIENT CHARACTERSTIC UNILATERAL N=37 BILATERAL N=32 DISCORDANT N=34 TOTAL N=131 p
Sex (M/%) 21 (57%) 19 (59%) 25 (74%) 81 (62%) 0.30
Age 52 [45–58] 50 [45–61] 50 [46–60] 57 [42–65] 0.98
sBP (mmHg) 150 [139–161] 160 [139–189] 156 [137–171] 156 [140–174] 0.15
dBP (mmHg) 90 [78–99] 89 [79–94] 86 [80–93] 88 [79–96] 0.50
ATC/DDD index 4.3 [2.3–5.6] 5.2 [1.7–7.1] 6.2 [3.4–8.4] 5 [2.7–7.1] 0.05
H/o hypokalemia (%) 97% 84% 94% 89% 0.12
PAC (ng/dL) 36 [25–61] 24* [18–33] 26* [22–40] 28 [22–40] 0.0007
PRA (ng/mL/hr) 0.2 [0.1–0.6] 0.3 [0.1–0.7] 0.4 [0.1–0.6] 0.3 [0.1–0.6] 0.86
ARR 105 [53–371] 86 [33–185] 74 [51–219] 89 [45–245] 0.24

Data are expressed as medians [interquartile range]. sBP, systolic blood pressure; dBP, diastolic blood pressure; ATC/DDD index, standardized daily defined dose of antihypertensive medications; PAC, plasma aldosterone concentration; PRA, plasma renin activity; ARR, PAC/PRA ratio; H/o, history of.

*

p < 0.05, compared with unilateral